FIELD: medicine.
SUBSTANCE: present group of inventions refers to medicine, namely to therapy and virology, and concerns treating and preventing infectious diseases caused by an influenza virus with type H1N1 surface antigen. That is ensured by administering a therapeutic agent containing an active substance in the form of a homoeopathically activated potentiated form prepared by multiple serial dilution of a stock solution of affine purified antibodies to human gamma-interferon in a concentration of 0.3÷5.0 mg/ml.
EFFECT: administering this therapeutic agent provides effective treatment and prevention of the above infectious diseases.
6 cl, 4 ex, 1 tbl
Authors
Dates
2014-09-10—Published
2010-02-27—Filed